Therefore, targeting Wnt16 signaling in osteoblasts represents a promising approach to enhance the natural repair processes of bone fragility fractures and bone-destructive diseases such as RA, osteoporosis, and periodontitis. This evidence concerns the gene WNT16 and rheumatoid arthritis.